QurCan Therapeutics Inc.
qurcan.comNanology Labs has designed and is developing Manganescan®, a novel theranostic agent (MRI contrast agent/Radio-sensitizer) that allows detection of brain tumors at early stages using MRI. Simultaneously, it sensitizes cancer cells which improves radiation therapy outcomes. The agent is 3x more sensitive than current Gadolinium contrast agents (GBCAs), can cross the blood brain barrier and enables early and precise detection and targeting of brain cancer.
Something looks off?Open jobs at QurCan Therapeutics Inc.
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.